High-mobility group box-1 (HMGB1), another canonical damage-associated molecular pattern, bridges early sterile inflammation and BBB injury (relevant to thrombolysis-related hemorrhage) with later neurovascular remodeling and atherogenesis, positioning it as both risk marker and candidate therapeutic target in postreperfusion care [71▪]. Here, HMGB1 is linked to hemorrhage.